190 related articles for article (PubMed ID: 9535886)
1. The effect of extracellular matrix proteins on porcine smooth muscle cell insulin-like growth factor (IGF) binding protein-5 synthesis and responsiveness to IGF-I.
Zheng B; Duan C; Clemmons DR
J Biol Chem; 1998 Apr; 273(15):8994-9000. PubMed ID: 9535886
[TBL] [Abstract][Full Text] [Related]
2. Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture.
Imai Y; Busby WH; Smith CE; Clarke JB; Garmong AJ; Horwitz GD; Rees C; Clemmons DR
J Clin Invest; 1997 Nov; 100(10):2596-605. PubMed ID: 9366575
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-I (IGF-I) regulates IGF-binding protein-5 synthesis through transcriptional activation of the gene in aortic smooth muscle cells.
Duan C; Hawes SB; Prevette T; Clemmons DR
J Biol Chem; 1996 Feb; 271(8):4280-8. PubMed ID: 8626775
[TBL] [Abstract][Full Text] [Related]
4. Binding of insulin-like growth factor (IGF)-binding protein-5 to smooth-muscle cell extracellular matrix is a major determinant of the cellular response to IGF-I.
Parker A; Rees C; Clarke J; Busby WH; Clemmons DR
Mol Biol Cell; 1998 Sep; 9(9):2383-92. PubMed ID: 9725901
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of IGFBP-5 binding to extracellular matrix and IGF-I-stimulated DNA synthesis by a peptide fragment of IGFBP-5.
Rees C; Clemmons DR
J Cell Biochem; 1998 Dec; 71(3):375-81. PubMed ID: 9831074
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism.
Pugliese G; Pricci F; Romeo G; Pugliese F; Mené P; Giannini S; Cresci B; Galli G; Rotella CM; Vlassara H; Di Mario U
Diabetes; 1997 Nov; 46(11):1881-7. PubMed ID: 9356040
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor binding protein-5 (IGFBP-5) interacts with thrombospondin-1 to induce negative regulatory effects on IGF-I actions.
Moralez AM; Maile LA; Clarke J; Busby WH; Clemmons DR
J Cell Physiol; 2005 May; 203(2):328-34. PubMed ID: 15700281
[TBL] [Abstract][Full Text] [Related]
8. Fibronectin and the basement membrane components laminin and collagen type IV influence the phenotypic properties of subcultured rat aortic smooth muscle cells differently.
Thyberg J; Hultgårdh-Nilsson A
Cell Tissue Res; 1994 May; 276(2):263-71. PubMed ID: 8020062
[TBL] [Abstract][Full Text] [Related]
9. Intrinsic actions of IGFBP-3 and IGFBP-5 on Hs578T breast cancer epithelial cells: inhibition or accentuation of attachment and survival is dependent upon the presence of fibronectin.
McCaig C; Perks CM; Holly JM
J Cell Sci; 2002 Nov; 115(Pt 22):4293-303. PubMed ID: 12376561
[TBL] [Abstract][Full Text] [Related]
10. Control of insulin-like growth factor binding protein-5 protease synthesis and secretion by human fibroblasts and porcine aortic smooth muscle cells.
Moralez A; Busby WH; Clemmons D
Endocrinology; 2003 Jun; 144(6):2489-95. PubMed ID: 12746311
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-binding protein-5 is cleaved by physiological concentrations of thrombin.
Zheng B; Clarke JB; Busby WH; Duan C; Clemmons DR
Endocrinology; 1998 Apr; 139(4):1708-14. PubMed ID: 9528953
[TBL] [Abstract][Full Text] [Related]
12. Involvement of ligand occupancy in Insulin-like growth factor-I (IGF-I) induced cell growth in osteoblast like MC3T3-E1 cells.
Kim SK; Kwon JY; Nam TJ
Biofactors; 2007; 29(4):187-202. PubMed ID: 18057550
[TBL] [Abstract][Full Text] [Related]
13. IGF-I induces collagen and IGFBP-5 mRNA in rat intestinal smooth muscle.
Zimmermann EM; Li L; Hou YT; Cannon M; Christman GM; Bitar KN
Am J Physiol; 1997 Oct; 273(4):G875-82. PubMed ID: 9357830
[TBL] [Abstract][Full Text] [Related]
14. Matrix-dependent gene expression of egr-1 and PDGF A regulate angiotensin II-induced proliferation in human vascular smooth muscle cells.
Ling S; Dai A; Ma YH; Wilson E; Chatterjee K; Ives HE; Sudhir K
Hypertension; 1999 Nov; 34(5):1141-6. PubMed ID: 10567196
[TBL] [Abstract][Full Text] [Related]
15. Vascular smooth muscle cells synthesize two forms of insulin-like growth factor binding proteins which are regulated differently by the insulin-like growth factors.
Cohick WS; Gockerman A; Clemmons DR
J Cell Physiol; 1993 Oct; 157(1):52-60. PubMed ID: 7691836
[TBL] [Abstract][Full Text] [Related]
16. Differential expression and biological effects of insulin-like growth factor-binding protein-4 and -5 in vascular smooth muscle cells.
Duan C; Clemmons DR
J Biol Chem; 1998 Jul; 273(27):16836-42. PubMed ID: 9642243
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-alpha regulates insulin-like growth factor-1 and insulin-like growth factor binding protein-3 expression in vascular smooth muscle.
Anwar A; Zahid AA; Scheidegger KJ; Brink M; Delafontaine P
Circulation; 2002 Mar; 105(10):1220-5. PubMed ID: 11889017
[TBL] [Abstract][Full Text] [Related]
18. Regulation of insulin-like growth factor (IGF) binding protein-2 synthesis and degradation by platelet-derived growth factor and the IGFs is enhanced by serum deprivation in vascular smooth muscle cells.
Cohick WS; Gockerman A; Clemmons DR
J Cell Physiol; 1995 Jul; 164(1):187-96. PubMed ID: 7540619
[TBL] [Abstract][Full Text] [Related]
19. [Effect of insulin and insulin-like growth factor-1 on vascular smooth muscle cells].
Saneshige S; Shigehiro K
Nihon Ronen Igakkai Zasshi; 1997 Jul; 34(7):548-54. PubMed ID: 9388374
[TBL] [Abstract][Full Text] [Related]
20. Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I.
Jones JI; Gockerman A; Busby WH; Camacho-Hubner C; Clemmons DR
J Cell Biol; 1993 May; 121(3):679-87. PubMed ID: 7683690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
